Karádi I - Search Results

1

Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index.

Yang Y, Chung EK, Zhou B, Blanchong CA, Yu CY, Füst G, Kovács M, Vatay A, Szalai C, Karádi I, Varga L. Yang Y, et al. Among authors: karadi i. J Immunol. 2003 Sep 1;171(5):2734-45. doi: 10.4049/jimmunol.171.5.2734. J Immunol. 2003. PMID: 12928427

2

Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations.

Vatay A, Yang Y, Chung EK, Zhou Bi, Blanchong CA, Kovács M, Karádi I, Füst G, Romics L L, Varga L, Yu CY, Szalai C. Vatay A, et al. Among authors: karadi i. Hum Immunol. 2003 May;64(5):543-52. doi: 10.1016/s0198-8859(03)00036-3. Hum Immunol. 2003. PMID: 12691705

3

Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior.

Füst G, Arason GJ, Kramer J, Szalai C, Duba J, Yang Y, Chung EK, Zhou B, Blanchong CA, Lokki ML, Bödvarsson S, Prohászka Z, Karádi I, Vatay A, Kovács M, Romics L, Thorgeirsson G, Yu CY. Füst G, et al. Among authors: karadi i. Int Immunol. 2004 Oct;16(10):1507-14. doi: 10.1093/intimm/dxh152. Epub 2004 Aug 31. Int Immunol. 2004. PMID: 15339882

4

The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.

Laki J, Kiszel P, Vatay A, Blaskó B, Kovács M, Körner A, Madácsy L, Blatniczky L, Almássy Z, Szalai C, Rajczy K, Pozsonyi E, Karádi I, Fazakas A, Hosszúfalusi N, Pánczél P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Füst G. Laki J, et al. Among authors: karadi i. Mol Immunol. 2007 Jan;44(4):648-55. doi: 10.1016/j.molimm.2006.01.011. Epub 2006 Feb 28. Mol Immunol. 2007. PMID: 16504296

5

Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease.

Kocsis J, Veres A, Vatay A, Duba J, Karádi I, Füst G, Prohászka Z. Kocsis J, et al. Among authors: karadi i. Immunol Invest. 2002 Aug-Nov;31(3-4):219-31. doi: 10.1081/imm-120016242. Immunol Invest. 2002. PMID: 12472181

6

Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women.

Széplaki G, Prohászka Z, Duba J, Rugonfalvi-Kiss S, Karádi I, Kókai M, Kramer J, Füst G, Kleiber M, Romics L, Varga L. Széplaki G, et al. Among authors: karadi i. Atherosclerosis. 2004 Dec;177(2):383-9. doi: 10.1016/j.atherosclerosis.2004.07.022. Atherosclerosis. 2004. PMID: 15530914

7

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.

Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H. Varga L, et al. Among authors: karadi i. Mol Immunol. 2007 Feb;44(6):1454-60. doi: 10.1016/j.molimm.2006.04.020. Epub 2006 Jun 5. Mol Immunol. 2007. PMID: 16750855

8

Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus.

Vatay A, Rajczy K, Pozsonyi E, Hosszúfalusi N, Prohászka Z, Füst G, Karádi I, Szalai C, Grósz A, Bártfai Z, Pánczél P. Vatay A, et al. Among authors: karadi i. Immunol Lett. 2002 Nov 1;84(2):109-115. doi: 10.1016/s0165-2478(02)00156-6. Immunol Lett. 2002. PMID: 12270547

9

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G. Vatay A, et al. Among authors: karadi i. Immunogenetics. 2003 Jul;55(4):247-52. doi: 10.1007/s00251-003-0575-8. Epub 2003 Jun 14. Immunogenetics. 2003. PMID: 12811429

10

Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability.

Prohászka Z, Duba J, Lakos G, Kiss E, Varga L, Jánoskuti L, Császár A, Karádi I, Nagy K, Singh M, Romics L, Füst G. Prohászka Z, et al. Among authors: karadi i. Int Immunol. 1999 Sep;11(9):1363-70. doi: 10.1093/intimm/11.9.1363. Int Immunol. 1999. PMID: 10464157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters